Factors of the Eating Inventory-51 (EI) were revealed as significant predictors of health risks. Associations of EI factors (restraint, disinhibition, hunger) with cardiometabolic risk parameters and selected hormones were analysed before and after an in-patient weight reduction programme. Sixty-seven women (age: 48.7 ± 12.2 years; body mass index: 32.4 ± 4.4 kg/m(2)), who exhibited stable weight on a 7 MJ/day diet during the first week, obtained a 4.5 MJ/day diet over the subsequent 3-week period. No significant relations were observed before the weight reduction. After weight loss, restraint score negatively correlated with total cholesterol, fasting blood glucose, C peptide, insulin and neuropeptide Y. Hunger score was positively related to insulin and neuropeptide Y. Disinhibition score correlated positively with lipid profile and neuropeptide Y, while negatively with adiponectin. An implementation of a standard dietary and lifestyle pattern for 3 weeks revealed significant associations between EI factors and metabolic risks in women.

• MeSH
• Adult MeSH
• Weight Loss * MeSH
• Body Mass Index MeSH
• Middle Aged MeSH
• Humans MeSH
• Obesity diet therapy   MeSH
• Diet, Reducing * MeSH
• Risk Factors MeSH
• Body Composition MeSH
• Feeding Behavior MeSH
• Body Weight MeSH
• Life Style * MeSH
• Check Tag
• Adult MeSH
• Middle Aged MeSH
• Humans MeSH
• Female MeSH
• Publication type
• Journal Article MeSH
• Research Support, Non-U.S. Gov't MeSH

• MeSH
• Bridged Bicyclo Compounds, Heterocyclic therapeutic use   MeSH
• Cyclobutanes therapeutic use   MeSH
• Lactones therapeutic use   MeSH
• Anti-Obesity Agents therapeutic use   MeSH
• Humans MeSH
• Obesity drug therapy   MeSH
• Orlistat MeSH
• Check Tag
• Humans MeSH
• Publication type
• Journal Article MeSH
• Research Support, Non-U.S. Gov't MeSH
• Names of Substances
• Bridged Bicyclo Compounds, Heterocyclic MeSH
• Cyclobutanes MeSH
• Lactones MeSH
• Anti-Obesity Agents MeSH
• Orlistat MeSH
• sibutramine MeSH Browser
• Tesofensine MeSH Browser